ReviewTherapeutic advances in medical oncology2021

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab.

Chiun Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.